187 related articles for article (PubMed ID: 18853344)
21. Nuclear factor kappaB signaling in atherogenesis.
de Winther MP; Kanters E; Kraal G; Hofker MH
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):904-14. PubMed ID: 15731497
[TBL] [Abstract][Full Text] [Related]
22. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
Mbalaviele G; Sommers CD; Bonar SL; Mathialagan S; Schindler JF; Guzova JA; Shaffer AF; Melton MA; Christine LJ; Tripp CS; Chiang PC; Thompson DC; Hu Y; Kishore N
J Pharmacol Exp Ther; 2009 Apr; 329(1):14-25. PubMed ID: 19168710
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage.
Ma CX; Yin WN; Cai BW; Wu J; Wang JY; He M; Sun H; Ding JL; You C
Chin Med J (Engl); 2009 Jul; 122(13):1575-81. PubMed ID: 19719951
[TBL] [Abstract][Full Text] [Related]
24. Signaling events leading to the curative effect of cystatin on experimental visceral leishmaniasis: involvement of ERK1/2, NF-kappaB and JAK/STAT pathways.
Kar S; Ukil A; Das PK
Eur J Immunol; 2009 Mar; 39(3):741-51. PubMed ID: 19197936
[TBL] [Abstract][Full Text] [Related]
25. NF-kappaB in liver diseases: a target for drug therapy.
Muriel P
J Appl Toxicol; 2009 Mar; 29(2):91-100. PubMed ID: 18937212
[TBL] [Abstract][Full Text] [Related]
26. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.
Acharyya S; Villalta SA; Bakkar N; Bupha-Intr T; Janssen PM; Carathers M; Li ZW; Beg AA; Ghosh S; Sahenk Z; Weinstein M; Gardner KL; Rafael-Fortney JA; Karin M; Tidball JG; Baldwin AS; Guttridge DC
J Clin Invest; 2007 Apr; 117(4):889-901. PubMed ID: 17380205
[TBL] [Abstract][Full Text] [Related]
27. META060 inhibits multiple kinases in the NF-kappaB pathway and suppresses LPS--mediated inflammation in vitro and ex vivo.
Desai A; Konda VR; Darland G; Austin M; Prabhu KS; Bland JS; Carroll BJ; Tripp ML
Inflamm Res; 2009 May; 58(5):229-34. PubMed ID: 19169645
[TBL] [Abstract][Full Text] [Related]
28. SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation?
Salminen A; Kauppinen A; Suuronen T; Kaarniranta K
Bioessays; 2008 Oct; 30(10):939-42. PubMed ID: 18800364
[TBL] [Abstract][Full Text] [Related]
29. Flower extract of Panax notoginseng attenuates lipopolysaccharide-induced inflammatory response via blocking of NF-kappaB signaling pathway in murine macrophages.
Jung HW; Seo UK; Kim JH; Leem KH; Park YK
J Ethnopharmacol; 2009 Mar; 122(2):313-9. PubMed ID: 19162159
[TBL] [Abstract][Full Text] [Related]
30. Treatment with inhibitors of the NF-kappaB pathway improves whole body tension development in the mdx mouse.
Siegel AL; Bledsoe C; Lavin J; Gatti F; Berge J; Millman G; Turin E; Winders WT; Rutter J; Palmeiri B; Carlson CG
Neuromuscul Disord; 2009 Feb; 19(2):131-9. PubMed ID: 19054675
[TBL] [Abstract][Full Text] [Related]
31. TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway.
Hess K; Ushmorov A; Fiedler J; Brenner RE; Wirth T
Bone; 2009 Aug; 45(2):367-76. PubMed ID: 19414075
[TBL] [Abstract][Full Text] [Related]
32. Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis.
Onizawa M; Nagaishi T; Kanai T; Nagano K; Oshima S; Nemoto Y; Yoshioka A; Totsuka T; Okamoto R; Nakamura T; Sakamoto N; Tsuchiya K; Aoki K; Ohya K; Yagita H; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G850-9. PubMed ID: 19179628
[TBL] [Abstract][Full Text] [Related]
33. Role of the NF-kappaB axis in immune modulation of osteoclasts and bone loss.
Abu-Amer Y; Darwech I; Otero J
Autoimmunity; 2008 Apr; 41(3):204-11. PubMed ID: 18365833
[TBL] [Abstract][Full Text] [Related]
34. Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy.
Ludwig S; Planz O
Biol Chem; 2008 Oct; 389(10):1307-12. PubMed ID: 18713017
[TBL] [Abstract][Full Text] [Related]
35. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model.
Kang HJ; Lee SH; Price JE; Kim LS
Breast J; 2009; 15(3):223-9. PubMed ID: 19645775
[TBL] [Abstract][Full Text] [Related]
36. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
37. Nuclear factor-kappa B in intestinal protection and destruction.
Spehlmann ME; Eckmann L
Curr Opin Gastroenterol; 2009 Mar; 25(2):92-9. PubMed ID: 19528876
[TBL] [Abstract][Full Text] [Related]
38. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis.
Elsharkawy AM; Mann DA
Hepatology; 2007 Aug; 46(2):590-7. PubMed ID: 17661407
[TBL] [Abstract][Full Text] [Related]
39. TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.
Funakoshi-Tago M; Kamada N; Shimizu T; Hashiguchi Y; Tago K; Sonoda Y; Kasahara T
Cytokine; 2009 Feb; 45(2):72-9. PubMed ID: 19091594
[TBL] [Abstract][Full Text] [Related]
40. Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis.
Roman-Blas JA; Jimenez SA
Int Rev Immunol; 2008; 27(5):351-74. PubMed ID: 18853343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
